242 related articles for article (PubMed ID: 18086342)
21. Effect of clofarabine on apoptosis and DNA synthesis in human epithelial colon cancer cells.
Wang X; Albertioni F
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):414-8. PubMed ID: 20544529
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of anti-cancer action and pharmacology of clofarabine.
Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
[TBL] [Abstract][Full Text] [Related]
23. Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma.
Ravandi F; Gandhi V
Expert Opin Investig Drugs; 2006 Dec; 15(12):1601-13. PubMed ID: 17107284
[TBL] [Abstract][Full Text] [Related]
24. In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia.
Homminga I; Zwaan CM; Manz CY; Parker C; Bantia S; Smits WK; Higginbotham F; Pieters R; Meijerink JP
Blood; 2011 Aug; 118(8):2184-90. PubMed ID: 21730354
[TBL] [Abstract][Full Text] [Related]
25. Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Cohen MH; Johnson JR; Massie T; Sridhara R; McGuinn WD; Abraham S; Booth BP; Goheer MA; Morse D; Chen XH; Chidambaram N; Kenna L; Gobburu JV; Justice R; Pazdur R
Clin Cancer Res; 2006 Sep; 12(18):5329-35. PubMed ID: 17000665
[TBL] [Abstract][Full Text] [Related]
26. Clofarabine: in pediatric patients with acute lymphoblastic leukemia.
Curran MP; Perry CM
Paediatr Drugs; 2005; 7(4):259-64; discussion 265-6. PubMed ID: 16117562
[TBL] [Abstract][Full Text] [Related]
27. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
Larson ML; Venugopal P
Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
[TBL] [Abstract][Full Text] [Related]
28. In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia.
Beesley AH; Palmer ML; Ford J; Weller RE; Cummings AJ; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Kees UR
Br J Haematol; 2007 Apr; 137(2):109-16. PubMed ID: 17391490
[TBL] [Abstract][Full Text] [Related]
29. Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine.
Jeha S
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1137-44, viii. PubMed ID: 19825457
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
Parker WB; Shaddix SC; Gilbert KS; Shepherd RV; Waud WR
Cancer Chemother Pharmacol; 2009 Jul; 64(2):253-61. PubMed ID: 19002461
[TBL] [Abstract][Full Text] [Related]
31. Clofarabine for the treatment of acute lymphoblastic leukemia.
Jeha S; Kantarjian H
Expert Rev Anticancer Ther; 2007 Feb; 7(2):113-8. PubMed ID: 17288522
[TBL] [Abstract][Full Text] [Related]
32. Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
Cooper T; Kantarjian H; Plunkett W; Gandhi V
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1417-23. PubMed ID: 15571270
[TBL] [Abstract][Full Text] [Related]
33. Nelarabine: efficacy in the treatment of clinical malignancies.
Roecker AM; Allison JC; Kisor DF
Future Oncol; 2006 Aug; 2(4):441-8. PubMed ID: 16922610
[TBL] [Abstract][Full Text] [Related]
34. Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemia.
Balakrishnan K; Ravandi F; Bantia S; Franklin A; Gandhi V
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):458-66. PubMed ID: 23773454
[TBL] [Abstract][Full Text] [Related]
35. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
Dressel A; Kwari M; McGreal AM
Clin J Oncol Nurs; 2011 Feb; 15(1):E13-23. PubMed ID: 21278032
[TBL] [Abstract][Full Text] [Related]
36. Clofarabine-induced capillary leak syndrome in a child with refractory acute lymphoblastic leukemia.
Baytan B; Ozdemir O; Gunes AM; Dönmez O
J Pediatr Hematol Oncol; 2010 Mar; 32(2):144-6. PubMed ID: 20057324
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.
Choi J; Foss F
Yale J Biol Med; 2006 Dec; 79(3-4):169-72. PubMed ID: 17940627
[TBL] [Abstract][Full Text] [Related]
38. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
Steinherz PG; Shukla N; Kobos R; Steinherz L
Pediatr Blood Cancer; 2010 May; 54(5):687-93. PubMed ID: 20205253
[TBL] [Abstract][Full Text] [Related]
39. The combination of clofarabine and cytarabine in pediatric relapsed acute lymphoblastic leukemia: a case report.
Gidwani P; Ramesh KH; Liu Y; Kolb EA
Chemotherapy; 2008; 54(2):120-4. PubMed ID: 18303261
[TBL] [Abstract][Full Text] [Related]
40. Forodesine in the treatment of cutaneous T-cell lymphoma.
Lewis DJ; Duvic M
Expert Opin Investig Drugs; 2017 Jun; 26(6):771-775. PubMed ID: 28447489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
